QLT is a biotechnology company dedicated to the development and commercialization of ocular products.
Dr. Anido previously served as president, CEO and a director of Ista Pharmaceuticals, which was recently acquired by Bausch & Lomb.
Prior to this position, Dr. Anido held positions with Windamere Venture Partners, CombiChem and the Americas Region of Allergan.
QLT is headquartered in Vancouver, Canada.
Related Articles on Ophthalmology:
Miami’s Bascom Palmer Eye Institute Ranked #1 Ophthalmology Program by U.S. News
Ophthalmologist William De La Peña to Serve on UCSF Advisory Board
tudy: Risk for Retinal Detachment After Phacoemulsification Declines
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
